Share on LinkedInShare on LinkedIn

ARTICLE · 11 JUNE 2020

Innovating During The COVID-19 Pandemic

McMillan LLP
McMillan LLP
Contributor
McMillan LLP

McMillan LLP

The firm : McMillan LLP is one of Canada’s leading national law firms with offices in Montreal,...

View firm profile
Explore more from McMillan LLP

During the COVID-19 pandemic, Canada continues to invest heavily into the research and development of innovative solutions to solve the challenges that we continue to face today.

CanadaCoronavirus (COVID-19)

Updated from June 4, 2020

During the COVID-19 pandemic, Canada continues to invest heavily into the research and development of innovative solutions to solve the challenges that we continue to face today.  Below is a summary of some of the opportunities that your business may be interested in exploring:

  • Clinical Trials: On May 23, 2020, Canada's Minister of Health issued an Interim Order with regard to clinical trials for medical devices and drugs related to COVID-19.  The Interim Order is intended to encourage clinical trials for novel and effective therapies and treatment options.  For more details on the Interim Order, please visit this link.

  • Community Health and Safety: As a part of its COVID-19 Program, the Digital Technology Supercluster is accepting submissions for projects related to health systems, community health, safe living, diagnostic and therapeutics, emergency response, and other technology solutions that can address the effects of

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The foregoing provides only an overview and does not constitute legal advice. Readers are cautioned against making any decisions based on this material alone. Rather, specific legal advice should be obtained.

© McMillan LLP 2025

See more popular content from